Clinical Trials for Drug: Bevacizumab

4 Open Trials. Phone:(877.827.8839)
Protocol No. Title Status
ECOG-EAF151 Change in Relative Cerebral Blood Volume as a Biomarker for Early Response to Bevacizumab in Patients with Recurrent Glioblastoma Open
UCI-14-58 Phase I, Multi-Center, Open-Label, Dose-Escalation, Combination Study of Marizomib and Bevacizumab in Bevacizumab-Naïve Subjects with WHO Grade IV Malignant Glioma Followed by Phase II Studies of Single Agent Marizomib and Combination Marizomib and Bevacizumab, and Phase I Dose-Escalation Study of Enternally-Administered Marizomib with Bevacizumab Open
UCI-14-67 A Phase II Study of Breast Cancer Treatment Using Weekly Carboplatin + Paclitaxel with Pertuzumab + Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting Open
UCI-17-107 A Phase III, Open-Label, Randomized Study of Atezolizumab in Combination with Bevacizumab Compared with Sorafenib in Patients with Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma Open